Newsmeme!
Discover News you didn't know existed
RNAi
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
It's Wait Until Next Year for These Drugmakers
Published December 1, 2008, 12:33 pm, The Motley Fool
Drugs from AstraZeneca and Eli Lilly face delays because of the FDA.
First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model
Published December 1, 2008, 12:10 pm, Medical News Today
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure(1).
Dicerna Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
Published December 1, 2008, 5:30 am, Business Wire via Yahoo! Finance
WATERTOWN, Mass.----Dicerna Pharmaceuticals, Inc. , a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™, today announced that James Jenson, Ph.D., chief executive officer of Dicerna, will present at the Piper Jaffray 20th Annual Health Care Conference on December 3, 2008 at 2:30 p.m. at The Palace Hotel in New York, ...
The path to a cure
Published December 1, 2008, 1:52 am, Worcester Telegram & Gazette
When Dr. Robert H. Brown Jr. says it, it sounds so simple.
Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ...
Published November 30, 2008, 10:21 am, Finanzen.net
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and ...
Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ...
Published November 30, 2008, 10:16 am, Centre Daily Times
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure (1) . The new findings demonstrated that miR-21 ...
Biotech Mailbag: All About Alnylam
Published November 28, 2008, 9:06 am, TheStreet.com
The stock hasn't been this low since July 2007, but lung drug data could set it up for a rebound.
Scientists Identify 13 New Tumor-suppressor Genes In Liver Cancer
Published November 27, 2008, 10:41 am, Science Daily
Researchers have developed a means of speeding up the discovery of cancer-related genes and validating their function in living animals. A collaborative effort yielded a large-scale, rapid, cost-effective genetic screen that in a preliminary test succeeded in uncovering 13 new tumor suppressors in human liver cancer, many of which have not been linked to cancer before.
Cellectricon and Harvard Medical School form collaboration
Published November 27, 2008, 2:56 am, Pharmaceutical Business Review
Cellectricon, a provider of automated screening solutions for drug discovery, has announced its collaboration with Harvard Medical School, the ICCB-Longwood screening facility.
Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
Published November 26, 2008, 1:18 pm, Centre Daily Times
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 20 th Annual Piper Jaffray Health Care Conference on Wednesday, December 3, 2008, at 9:00 a.m. ET at The New York Palace Hotel in New York City.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |